Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association.

The Journal of Biological Chemistry
P HolvoetD Collen


In the present study, the lipoprotein association of apoA-I, an apoA-I (DeltaAla190-Gln243) deletion mutant and an apoA-I (Asp1-Leu189)/apoA-II (Ser12-Gln77) chimera were compared. At equilibrium, 80% of the 125I-labeled apolipoproteins associated with lipoproteins in rabbit or human plasma but with very different distribution profiles. High density lipoprotein (HDL)2,3-associated fractions were 0.60 for apoA-I, 0.30 for the chimera, and 0.15 for the deletion mutant, and corresponding very high density lipoprotein-associated fractions were 0.20, 0.50, and 0.65. Clearance curves after intravenous bolus injection of 125I-labeled apolipoproteins (3 microg/kg) in normolipemic rabbits could be adequately fitted with a sum of three exponential terms, yielding overall plasma clearance rates of 0.028 +/- 0.0012 ml.min-1 for apoA-I (mean +/- S.E.; n = 6), 0.10 +/- 0.008 ml.min-1 for the chimera (p < 0.001 versus apoA-I) and 0.38 +/- 0.022 ml.min-1 for the deletion mutant (p < 0.001 versus apoA-I and versus the chimera). Fractions that were initially cleared with a t1/2 of 3 min, most probably representing free apolipoproteins, were 0.30 +/- 0.04, 0.50 +/- 0.06 (p = 0.02 versus apoA-I), and 0.64 +/- 0.07 (p = 0.002 versus apoA-I), respec...Continue Reading


Feb 14, 1978·Biochemical and Biophysical Research Communications·H B BrewerT J Bronzert
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jan 1, 1990·Proteins·J P SegrestG M Anantharamaiah
Nov 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J C ChristianP D Wood
Apr 17, 1990·Biochimica Et Biophysica Acta·R BrasseurM Rosseneu
Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Feb 25, 1972·Biochemical and Biophysical Research Communications·C J FieldingP E Fielding
Mar 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·G Assmann, H B Brewer
Jan 1, 1983·Molecular and Cellular Biochemistry·J Loeb, G Dawson
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C J Fielding, P E Fielding
Mar 10, 1995·The Journal of Biological Chemistry·H H SchmidtJ M Hoeg


Jan 27, 1999·Atherosclerosis·C R SirtoriG Franceschini
Dec 22, 1999·Biochimica Et Biophysica Acta·V Narayanaswami, R O Ryan
Oct 31, 2013·Journal of Medicinal Chemistry·Luke J LemanM Reza Ghadiri
Dec 30, 2014·Critical Reviews in Clinical Laboratory Sciences·Andreja TrpkovicEsma R Isenovic
Oct 3, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Dieuwke De KeyzerE Ninio
Apr 12, 2003·The Journal of Biological Chemistry·Kerry-Anne RyePhilip J Barter
Apr 10, 2003·The Journal of Biological Chemistry·Robert S KissR O Ryan

Related Concepts

DNA Sequence
Alkalescens-Dispar Group
Homo sapiens
Alpha-1 Lipoprotein
Molecular Sequence Data
Plasma Protein Binding Capacity
Protein Conformation
Pro-Apolipoprotein A-I

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.